Glycosylation profiles of epitope-specific anti-beta-amyloid antibodies revealed by liquid chromatography mass spectrometry

Lade...
Vorschaubild
Dateien
SCAN_Przybylski_Michael2009_n.pdf
SCAN_Przybylski_Michael2009_n.pdfGröße: 1.29 MBDownloads: 335
Datum
2009
Autor:innen
Perdivara, Irina
Deterding, Leesa J.
Tomer, Kenneth B.
Herausgeber:innen
Kontakt
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
ArXiv-ID
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Open Access Green
Sammlungen
Core Facility der Universität Konstanz
Gesperrt bis
Titel in einer weiteren Sprache
Forschungsvorhaben
Organisationseinheiten
Zeitschriftenheft
Publikationstyp
Zeitschriftenartikel
Publikationsstatus
Published
Erschienen in
Glycobiology. 2009, 19(9), pp. 958-970. ISSN 0959-6658. eISSN 1460-2423. Available under: doi: 10.1093/glycob/cwp038
Zusammenfassung

Alzheimer's disease (AD) is the most prevalent form of age-related neurodementia. The accumulation of β-amyloid polypeptide (Aβ) in brain is generally believed to be a key event in AD. The recent discovery of physiological β-amyloid autoantibodies represents a promising perspective for treatment and early diagnosis of AD. The mechanisms by which natural β-amyloid autoantibodies prevent neurodegeneration are currently unknown. The aim of the present study was to analyze the N-linked glycosylation of a plaque-specific, monoclonal antibody (clone 6E10) relevant for immunotherapy of AD, in comparison with the glycosylation pattern of an Aβ autoantibody isolated from an IgG source. Liquid chromatography in combination with tandem mass spectrometry was used to analyze the glycopeptides generated by enzymatic degradation of the antibodies reduced and alkylated heavy chains. The oligosaccharide pattern of the 6E10 antibody shows primarily core-fucosylated biantennary complex structures and, to a low extent, tri- and tetragalactosyl glycoforms, with or without terminal sialic acids. The glycans associated with the serum anti-Aβ autoantibodies are of the complex, biantennary-type, fucosylated at the first N-acetyl glucosamine residue of the trimannosyl chitobiose core and contain zero to two galactose residues, and zero to one terminal sialic acid, with or without bisecting N-acetyl glucosamine. Glycosylation analysis of the Aβ-autoantibody performed at the peptide level revealed all four human IgG subclasses, with IgG1 and IgG2 as the dominant subclasses.

Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
540 Chemie
Schlagwörter
A-beta autoantibody, Glycopeptides, Glycosylation structures, Immunoglobulin subclass, Mass spectrometry
Konferenz
Rezension
undefined / . - undefined, undefined
Zitieren
ISO 690PERDIVARA, Irina, Leesa J. DETERDING, Claudia COZMA, Kenneth B. TOMER, Michael PRZYBYLSKI, 2009. Glycosylation profiles of epitope-specific anti-beta-amyloid antibodies revealed by liquid chromatography mass spectrometry. In: Glycobiology. 2009, 19(9), pp. 958-970. ISSN 0959-6658. eISSN 1460-2423. Available under: doi: 10.1093/glycob/cwp038
BibTex
@article{Perdivara2009Glyco-10050,
  year={2009},
  doi={10.1093/glycob/cwp038},
  title={Glycosylation profiles of epitope-specific anti-beta-amyloid antibodies revealed by liquid chromatography mass spectrometry},
  number={9},
  volume={19},
  issn={0959-6658},
  journal={Glycobiology},
  pages={958--970},
  author={Perdivara, Irina and Deterding, Leesa J. and Cozma, Claudia and Tomer, Kenneth B. and Przybylski, Michael}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/10050">
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/10050/1/SCAN_Przybylski_Michael2009_n.pdf"/>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-24T18:16:14Z</dc:date>
    <dc:creator>Deterding, Leesa J.</dc:creator>
    <dcterms:bibliographicCitation>First publ. in: Glycobiology 19 (2009), 9, pp. 958-970</dcterms:bibliographicCitation>
    <dcterms:abstract xml:lang="eng">Alzheimer's disease (AD) is the most prevalent form of age-related neurodementia. The accumulation of β-amyloid polypeptide (Aβ) in brain is generally believed to be a key event in AD. The recent discovery of physiological β-amyloid autoantibodies represents a promising perspective for treatment and early diagnosis of AD. The mechanisms by which natural β-amyloid autoantibodies prevent neurodegeneration are currently unknown. The aim of the present study was to analyze the N-linked glycosylation of a plaque-specific, monoclonal antibody (clone 6E10) relevant for immunotherapy of AD, in comparison with the glycosylation pattern of an Aβ autoantibody isolated from an IgG source. Liquid chromatography in combination with tandem mass spectrometry was used to analyze the glycopeptides generated by enzymatic degradation of the antibodies reduced and alkylated heavy chains. The oligosaccharide pattern of the 6E10 antibody shows primarily core-fucosylated biantennary complex structures and, to a low extent, tri- and tetragalactosyl glycoforms, with or without terminal sialic acids. The glycans associated with the serum anti-Aβ autoantibodies are of the complex, biantennary-type, fucosylated at the first N-acetyl glucosamine residue of the trimannosyl chitobiose core and contain zero to two galactose residues, and zero to one terminal sialic acid, with or without bisecting N-acetyl glucosamine. Glycosylation analysis of the Aβ-autoantibody performed at the peptide level revealed all four human IgG subclasses, with IgG1 and IgG2 as the dominant subclasses.</dcterms:abstract>
    <dc:contributor>Perdivara, Irina</dc:contributor>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/10050"/>
    <dc:creator>Perdivara, Irina</dc:creator>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/>
    <dc:contributor>Cozma, Claudia</dc:contributor>
    <dcterms:title>Glycosylation profiles of epitope-specific anti-beta-amyloid antibodies revealed by liquid chromatography mass spectrometry</dcterms:title>
    <dc:contributor>Przybylski, Michael</dc:contributor>
    <dc:rights>terms-of-use</dc:rights>
    <dc:language>eng</dc:language>
    <dc:creator>Cozma, Claudia</dc:creator>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-24T18:16:14Z</dcterms:available>
    <dc:format>application/pdf</dc:format>
    <dcterms:issued>2009</dcterms:issued>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dc:contributor>Tomer, Kenneth B.</dc:contributor>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/29"/>
    <dc:contributor>Deterding, Leesa J.</dc:contributor>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:creator>Tomer, Kenneth B.</dc:creator>
    <dc:creator>Przybylski, Michael</dc:creator>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/10050/1/SCAN_Przybylski_Michael2009_n.pdf"/>
  </rdf:Description>
</rdf:RDF>
Interner Vermerk
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Kontakt
URL der Originalveröffentl.
Prüfdatum der URL
Prüfungsdatum der Dissertation
Finanzierungsart
Kommentar zur Publikation
Allianzlizenz
Corresponding Authors der Uni Konstanz vorhanden
Internationale Co-Autor:innen
Universitätsbibliographie
Ja
Begutachtet
Diese Publikation teilen